The repair deficiency may partly relate to a diabetes-associated downregulation of BRCA1/2 function in breast tumors, as our data suggest, and to metabolic alterations that increase oxidative stress and reduce the availability of α-ketoglutarate. Here, BRCA1 is linked to diabetes mellitus.